SGRYSurgery Partners, Inc.

$13.94

The financials

Surgery Partners, Inc. by the numbers

Surgery Partners, Inc. (SGRY) reported revenue of $849M in Q2 2026 (quarter ended Jun 30, 2026), up 2.7% from the same quarter a year earlier. That came with net loss of $15M. For the full year FY2025, revenue was $3.31B (+6.2% year on year) and net income −$78M. Its largest product in Q2 2026 was Private Insurance at $401M, 47% of the disclosed total, just ahead of Government at 45%.

Surgery Partners, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$849M$826M+2.7%
Operating income$102M$112M−8.6%
Net income−$15M−$2.5Mn/a
Diluted EPS−$0.12−$0.02n/a
Revenue by product, Q2 2026, as reported to the SEC
ProductRevenueShare
Private Insurance$401M47%
Government$381M45%
Self Pay$24M2.8%
Other Services$23M2.7%
Other Patient Service Revenue Sources$21M2.4%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q2 2026Total $848.9M (+4.7%)
Other Patient Service Revenue Sources grew +15% year on yearPrivate Insurance -4.3% year on year
  • Private Insurance$401.4MQoQ +0.63%year on year -4.3%
  • Government$380.6MQoQ +6.5%year on year +10%
  • Self Pay$23.5MQoQ +22%year on year +7.3%
  • Other Services$22.8MQoQ +21%year on year +3.6%
  • Other Patient Service Revenue Sources$20.6MQoQ +24%year on year +15%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed 2026-08-10, SEC EDGAR